This week, Hillary Clinton has dusted off one of the Democrats' favorite health care bogeymen — Big Pharma. But there's no data to support her claims that drug spending is out of control.
Read more at Investor's Business Daily
(Hat tip: KimR)
Thursday, September 24, 2015
Hillary's drug price control plan is based on one big lie
Labels:
Big Pharma,
drugs,
Hillary Clinton,
R&D
Subscribe to:
Post Comments (Atom)







No comments:
Post a Comment